| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/04/2003 | WO2003018743A3 Emu-based formulations for wound treatment |
| 09/04/2003 | WO2003013647A3 Electrodes coated with treating agent and uses thereof |
| 09/04/2003 | WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 09/04/2003 | WO2003002593A3 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 09/04/2003 | WO2002088106A3 Cysteine protease inhibitors |
| 09/04/2003 | WO2002083858A8 Methods to inhibit viral replication |
| 09/04/2003 | WO2002078600A3 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/04/2003 | WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/04/2003 | WO2002068058A3 Dapd combination therapy with imdph inhibitors such as ribavirin or mycophenolic acid |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 09/04/2003 | WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002032932A3 Urotensin-ii agonists and antagonists |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002009760A9 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 09/04/2003 | WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 09/04/2003 | WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2003 | US20030166935 Spiroazabicyclic heterocyclic compounds |
| 09/04/2003 | US20030166928 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 09/04/2003 | US20030166927 1,5-Benzothiazepines and their use as hypolipidaemics |
| 09/04/2003 | US20030166925 4-Substituted piperidine compound |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166910 Bone morphogenic protein |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166883 Genetic engineering; drug screening |
| 09/04/2003 | US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166847 Novel human leptin receptor gene-related protein |
| 09/04/2003 | US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof |
| 09/04/2003 | US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines |
| 09/04/2003 | US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives |
| 09/04/2003 | US20030166720 Administering a therapeutic combination comprising a first amount of a fibric acid derivative and a second amount of a cholesteryl ester transfer protein inhibitor effective for treatment of hyperlipidemic conditions |
| 09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 09/04/2003 | US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 09/04/2003 | US20030166711 A non-peptide and a non- nucleotide compound, culture product of penicillium sp. SPF-3059 |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166691 Phenylalanine derivatives |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166681 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 09/04/2003 | US20030166680 For treating serine protease or dual-serine protease mediated disorders |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166664 E.g. 3-(1-(2-(5-(acetylamino)-2-methylphenyl)ethyl)piperidin--4-yl)-6-chloro-1H -indole; potent dopamine D4 ligands, dopamine antagonists; antiseratonin agents; psychoses; anxiolytic agents; antidepressants; side effects reduction |
| 09/04/2003 | US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders |
| 09/04/2003 | US20030166654 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 09/04/2003 | US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 09/04/2003 | US20030166652 Chemical compounds |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166642 Administering synergistic mixtures of phenothiazine and pentamidine derivatives as anticarcinogenic agents |
| 09/04/2003 | US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 09/04/2003 | US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists |
| 09/04/2003 | US20030166633 Pyridinylimidazoles |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents |
| 09/04/2003 | US20030166619 N2O2- functionality is bound direct to a carbon atom; treating biological disorders hypertension, restenosis, impotency, genetic disorders or infections |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030166610 Nutritional composition |
| 09/04/2003 | US20030166601 Drug delivery of the nucleic acid into a target tissue or cell, comprising a core complex contains a nucleic acid and complex forming agents, fusion with cell membranes with nuclear uptake; polymeric outer shell |
| 09/04/2003 | US20030166592 For treatment of metabolic disorders (diabetes, obesity) |
| 09/04/2003 | US20030166591 Testosterone-repressed prostate message-2 (TRPM-2); gene expression inhibition; increased antitumor activity |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166585 Substituted tetracycline compounds as synergistic antifungal agents |
| 09/04/2003 | US20030166582 Aryl fused azapolycyclic compounds |
| 09/04/2003 | US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation |
| 09/04/2003 | US20030166577 Inhibitors for the blood-clotting factor xa |
| 09/04/2003 | US20030166576 Urokinase inhibitors |
| 09/04/2003 | US20030166572 2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives |
| 09/04/2003 | US20030166568 Organic compounds |
| 09/04/2003 | US20030166562 Treatment for asthma or allergies |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166546 Uses of THANK, a TNF homologue that activates apoptosis |
| 09/04/2003 | US20030166545 Compounds and use thereof to modify transport across cell membranes |
| 09/04/2003 | US20030166543 Functional antagonists of hedgehog activity |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents. |
| 09/04/2003 | US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes, |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166523 Activating only the vascular endothelial growth factor receptor-3 has been created. The method comprises administration of a composition comprising a polypeptide to an animal wherein the composition has the ability to stimulate |
| 09/04/2003 | US20030166521 Inhibition of thrombosis by treatment with P-selectin antagonists |
| 09/04/2003 | US20030166257 Use of Lactobacillus salivarius |
| 09/04/2003 | US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |